Page 79 - JCTR-11-4
P. 79

Journal of Clinical and
            Translational Research                                              Adherence and psoriasis severity in Brazil



            Appendix


                                      Table A1. Topical treatments used by study participants
                                      Treatment                           n      %
                                      Corticosteroid                      81    60.90
                                      Calcipotriol                        41    30.82
                                      Salicylic acid                      15    11.27
                                      Common moisturizer                  10    7.51
                                      Coal tar or liquor carbonis detergens  6  4.51
                                      Urea                                5     3.75
                                      Tacrolimus or pimecrolimus          1     0.75
                                      Anti-dandruff shampoo               1     0.75
                                      Manipulated formula (silicone+osu+ceramides)  1  0.75

                                      Table A2. Systemic medications used by study participants

                                      Treatment                 n                %
                                      Methotrexate              28              21.05
                                      Acitretin                 14              10.52
                                      Cyclosporine               4              3.00
                                      Corticosteroid             3              2.25
                                      Leflunomide                2              1.50
                                      8-methoxypsoralen          1              0.75


                                      Table A3. Immunobiologicals used by study participants
                                      Treatment               n                 %
                                      Secukinumab             23               17.29
                                      Adalimumab              22               16.54
                                      Ustekinumab             11                8.27
                                      Etanercept               2                1.50
                                      Risankizumab             2                1.50
                                      Infliximab               1                0.75
                                      Ixekizumab               1                0.75
























            Volume 11 Issue 4 (2025)                        73                            doi: 10.36922/jctr.24.00057
   74   75   76   77   78   79   80   81   82   83   84